Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
Chiun Hsu(National Taiwan University Hospital), Da‐Liang Ou(National Taiwan University)
Cited by 49
Related Papers
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|Journal for ImmunoTherapy of Cancer|2021|144
Alcoholism and Alcoholic Organ Damage and Genetic Polymorphisms of Alcohol Metabolizing Enzymes in Chinese Patients
|Hepatology|1997|124